Dr. Seulki Lee is Associate Professor of Radiology and Radiological Science with secondary appointments in Ophthalmology, Oncology and Materials Science and Engineering and a member of the Johns Hopkins Kimmel Cancer Center. His research group focuses on exploring GLP-1 signaling in neurodegenerative disorders and TRAIL signaling in fibrosis diseases and cancer for the development of novel therapies. Dr. Lee is an expert in drug and protein drug delivery, nanotechnology and molecular imaging leading to more than 140 articles in peer-reviewed journals and 20 patents for drug/protein deliver and diagnostic imaging methods.
Prior to joining Johns Hopkins, Dr. Lee was the inaugural section leader of the Theranostic Nanomedicine Section at the National Institute of Biomedical Imaging and Bioengineering (NIBIB/NIH). Currently, his team is evolving its research endeavors from drug delivery to explore TRAIL biology in fibrosis and cancer towards clinical translation.
Dr. Lee has received multiple awards, including the NRC Associateship from the National Academy of Sciences, the NIH Pathway to Independence Award (K99/R00), Career Development Award and Investigator-Initiated Research Award from the Department of Defense, Thome Memorial Foundation Award and the Maryland Innovation Initiative Award. Dr. Lee was selected as a 2017 Highly Cited Researchers.